Showing 101 - 120 results of 240 for search '"hepatitis B virus"', query time: 0.10s Refine Results
  1. 101

    STUDI PERBANDINGAN PEMAKAIAN PRIMER HBS1 DAN HBS2 DENGAN PRIMER P7 DAN P8 DALAM DETEKSI DNA VIRUS HEPATITIS B PADA PENDONOR DARAH by Supiana Dian Nurtjahyani, Mohammad Amin, Retno Handajan

    Published 2020-11-01
    “…Examination of the hepatitis B virus as a disease of hepatitis serologically has been carried out a lot, but this serological examination can experience problems if there is a low window period, so even though a negative test result is still possible in a patient's body infected with the hepatitis B virus, a fast and accurate examination is needed. …”
    Get full text
    Article
  2. 102

    Low viral persistence of an immunological model by Suqi Ma

    Published 2012-09-01
    “…Hepatitis B virus can persist at very low levels in the body in the face of host immunity, and reactive during immunosuppression and sustain the immunological memory to lead to the possible state of 'infection immunity'. …”
    Get full text
    Article
  3. 103

    Epidemiology of Hepatitis B in Canada by Jun Zhang, Shimian Zou, Antonio Giulivi

    Published 2001-01-01
    “…OBJECTIVE: To provide a current and comprehensive review of the epidemiology of hepatitis B virus (HBV) in Canada.…”
    Get full text
    Article
  4. 104

    The Investigation of HBV Pre-S/S Gene Mutations in Occult HBV Infected Blood Donors with anti-HBs Positive by Yan Guo, Yu Lan, Yuanyuan Jing, Bin Cai, Hanshi Gong, Yixin Zhang, Yong Duan

    Published 2022-01-01
    “…The coexistence of hepatitis B virus (HBV) and hepatitis B surface antibodies (anti-HBs) in occult hepatitis B virus infection (OBI) is a contradictory phenomenon, and the underlying mechanism is not fully understood. …”
    Get full text
    Article
  5. 105

    Prevalence of HDV, HCV, and HIV Infection in the Population of Patients Infected with HBV in a Romanian Cohort by Antoanela Curici, Olivia Mioara Ilie, Dana Elena Mindru

    Published 2025-01-01
    “…Hepatitis B virus (HBV) infections remain a significant global health challenge, especially in low- and middle-income countries where access to healthcare services is often limited. …”
    Get full text
    Article
  6. 106

    Seroprevalence of Cytomegalovirus, Toxoplasma gondii, Syphilis, and Hepatitis B and C Virus Infections in a Regional Population Seropositive for HIV Infection by Daniel G Johns, M John Gill

    Published 1998-01-01
    “…OBJECTIVE: To determine the prevalence of exposure to cytomegalovirus (CMV), Toxoplasma gondii, syphilis, hepatitis B virus (HBV) and hepatitis C virus (HCV) in a large, well characterized, regional population presenting for human immunodeficency virus (HIV) care.…”
    Get full text
    Article
  7. 107

    Acute Coinfection with Hepatitis B and Hepatitis C Viruses by Brian M Yan, Samuel S Lee

    Published 2005-01-01
    “…Acute coinfection of hepatitis B virus (HBV) and hepatitis C virus (HCV) is rare. …”
    Get full text
    Article
  8. 108

    Hepatitis C pada Anak by Yusri Dianne Jurnalis, Yorva Sayoeti, Adria Russelly

    Published 2014-05-01
    “…Infeksi HCV akut dapat berakhir dengan sirosis dan karsinoma hepatoselular setelah dekade ketiga (sekitar 20%), karena progresivitas infeksi HCV lebih lambat dari infeksi hepatitis B virus. Pada umumnya infeksi HCV bersifat asimptomatik termasuk pada anak. …”
    Get full text
    Article
  9. 109

    Efficacy and safety of tenofovir and entecavir in patients with chronic hepatitis B-related cirrhosis: a systematic review and meta-analysis by Lu Cao, Li Li, Lixing Yang, Nan Zhou, Yu Zhang

    Published 2025-01-01
    “…After 48 weeks, the hepatitis B virus-deoxyribonucleic acid clearance rate in the tenofovir group were comparable to the entecavir group. …”
    Get full text
    Article
  10. 110

    Chronic Liver Disease in Ethiopia with a Particular Focus on the Etiological Spectrums: A Systematic Review and Meta-Analysis of Observational Studies by Behailu Terefe Tesfaye, Temesgen Mulugeta Feyissa, Azmeraw Bekele Workneh, Esayas Kebede Gudina, Mengist Awoke Yizengaw

    Published 2021-01-01
    “…On the other hand, the overall hospital mortality rate in CLD patients is 25.0% [95% CI: 2.0, 47.0, I2 = 94.6, p<0.001] in Ethiopia. Conclusion. Hepatitis B virus, hepatitis C virus, and alcohol are the three most common contributors to CLD cases in Ethiopia. …”
    Get full text
    Article
  11. 111

    Antiviral therapy can effectively suppress irAEs in HBV positive hepatocellular carcinoma treated with ICIs: validation based on multi machine learning by Shuxian Pan, Zibing Wang

    Published 2025-01-01
    “…BackgroundImmune checkpoint inhibitors have proven efficacy against hepatitis B-virus positive hepatocellular. However, Immunotherapy-related adverse reactions are still a major challenge faced by tumor immunotherapy, so it is urgent to establish new methods to effectively predict immunotherapy-related adverse reactions.ObjectiveMulti-machine learning model were constructed to screen the risk factors for irAEs in ICIs for the treatment of HBV-related hepatocellular and build a prediction model for the occurrence of clinical IRAEs.MethodsData from 274 hepatitis B virus positive tumor patients who received PD-1 or/and CTLA4 inhibitor treatment and had immune cell detection results were collected from Henan Cancer Hospital for retrospective analysis. …”
    Get full text
    Article
  12. 112

    Attitude and Vaccination Status of Healthcare Workers against Hepatitis B Infection in a Teaching Hospital, Ethiopia by Mohammed Akibu, Sodere Nurgi, Mesfin Tadese, Wendwesen Dibekulu Tsega

    Published 2018-01-01
    “…World Health Organization and Centers for Disease Control and Prevention recommend all health professionals to get vaccinated against hepatitis B virus before they start the clinical attachments during their stay in the medical school. …”
    Get full text
    Article
  13. 113

    Clinical Feature of Intrahepatic B-Lymphocytes in Chronic Hepatitis B by Ashraf Mohamadkhani, Elnaz Naderi, Masoud Sotoudeh, Aezam Katoonizadeh, Ghodratollah Montazeri, Hossein Poustchi

    Published 2014-01-01
    “…However, the association of hepatic injury and B-cells population in chronic hepatitis B virus (HBV) carriers has not been studied well. …”
    Get full text
    Article
  14. 114

    Hepatitis B Infection and Liver Transplantation by Eric M Yoshida

    Published 1997-01-01
    “…Patients with chronic hepatitis B virus (HBV) infection have historically incurred high rates of allograft reinfection from extrahepatic reservoirs of HBV, with worse long term outcome compared with that of transplant recipients without HBV infection. …”
    Get full text
    Article
  15. 115

    Reassessing the Role for Lamivudine in Chronic Hepatitis B Infection: A Four-Year Cohort Analysis by Tahir Shaikh, Curtis Cooper

    Published 2012-01-01
    “…The data supporting the use of antiviral agents other than lamivudine in the management of patients with hepatitis B virus (HBV) infection are based on highly selected clinical trial populations that may not be representative of typical HBV-infected populations encountered in many clinics. …”
    Get full text
    Article
  16. 116

    Principles in the Management of Chronic Hepatitis B Viral Infection by Gerald Y Minuk

    Published 1999-01-01
    “…Recently licensed and promising new experimental agents should have a profound impact on the treatment of patients with chronic hepatitis B virus (HBV) infection. However, certain management principles should remain unaltered. …”
    Get full text
    Article
  17. 117

    Identification of Acute Vaccine-Preventable Hepatitis in Individuals with Chronic Hepatitis in British Columbia between 1991 and 2007 by Lily Fang, Amanda Yu, Jane A. Buxton

    Published 2011-01-01
    “…BACKGROUND: In British Columbia (BC), hepatitis A virus (HAV) and hepatitis B virus (HBV) vaccines are provincially funded for persons with chronic hepatitis infections. …”
    Get full text
    Article
  18. 118

    Viral Hepatitis B and Its Implications for Public Health in DR Congo: A Systematic Review by Marcellin Mengouo Nimpa, Hermès Karemere, Christian Ngandu, Franck-Fortune Mboussou, M. Carolina Danovaro-Holliday, Dalau Nkamba, André Bita Fouda, Bienvenu Nguejio, Sifa Kakozi, Aimé Mwana-Wabene Cikomola, Jean-Crispin Mukendi, Dieudonné Mwamba, Moise Désiré Yapi, Richard Bahizire Riziki, Cedric Mwanga, John Otomba, Jean Baptiste Nikiema, Boureima Hama Sambo, Daniel Katuashi Ishoso

    Published 2024-12-01
    “…<b>Background:</b> The prevalence of hepatitis B virus infection remains high in the Democratic Republic of Congo (DRC), constituting a public health problem in view of the fatal complications it causes, notably cirrhosis and hepatocellular carcinoma. …”
    Get full text
    Article
  19. 119

    Unusual Presentation of Gianotti-Crosti Syndrome due to Epstein-Barr Virus Infection by Hind Saif Al Dhaheri, Amani Al Kaabi, Yasmin Kara Hamo, Aysha Al Kaabi, Salwa Al Kaabi, Hossam Al Tatari

    Published 2016-01-01
    “…It has been classically associated with hepatitis B virus, as well as rarely with Epstein-Barr virus (EBV). …”
    Get full text
    Article
  20. 120

    Hepatitis B and Hepatitis C Viral Infections in Patients with Chronic Lymphocytic Leukemia by Gerald Y Minuk, Betty Lerner, Spencer B Gibson, James B Johnston, Julia Uhanova, Anton Andonov, Jun Wu

    Published 2014-01-01
    “…BACKGROUND: Whether chronic hepatitis B virus (HBV) or hepatitis C virus (HCV) infections contribute to the pathogenesis and/or course of chronic lymphocytic leukemia is unclear.…”
    Get full text
    Article